Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
disguise's Polygon Labs acquisition delivers the ultimate solution for broadcast graphics production
London, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Today, disguise launches its first integrated hardware and software solution for cloud-native broadcast graphics production. Developed with Polygon Labs –...
-
LONDON, Sept. 01, 2022 (GLOBE NEWSWIRE) -- According to The Business Research Company’s research report on the auto-dimming mirror market, the surge in the automotive industry is expected to propel...
-
SAN JOSE, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: SYNA) today announced that the evaluation kit (EVK) for its Katana ultra-low-power Edge AI SoC platform is now...
-
Portland, OR, Sept. 01, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global hydrogen powered engine market generated $34.7 billion in 2030, and is...
-
London, Sept. 01, 2022 (GLOBE NEWSWIRE) -- How has Web 3.0, also known as the ‘third generation of the evolution of the World Wide Web’, affected social media and marketers? Web 2.0, which was...
-
PHOENIX, Sept. 01, 2022 (GLOBE NEWSWIRE) -- The Air Conditioning Contractors of America (ACCA) has teamed up with Pearl Certification to present The Solar Forum — the nation's first-ever event to...
-
Wilmington, Delaware, United States, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - Various stakeholders operating in the automotive electric water pump market are geared...
-
New York, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Hybrid Train Market by Propulsion Type, Application, Operating Speed, Battery Technology and Region...
-
Bagsværd, Denmark and Watertown, Mass, US, 01 September 2022 – Novo Nordisk and Forma Therapeutics, Holdings Inc. (Nasdaq: FMTX) today announced that they have entered into a definitive agreement...
-
BOSTON, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families...